Sandhoff Disease Treatment Market: How Is Hematopoietic Stem Cell Transplantation with Enzyme Replacement Adjuncts Becoming the Fastest-Growing Disease-Modifying Strategy?
Hematopoietic stem cell transplantation (HSCT) combined with substrate reduction and investigational enzyme replacement — the disease-modifying approach utilizing umbilical cord blood or bone marrow transplantation to restore hexosaminidase A and B activity in Sandhoff disease (GM2 gangliosidosis) patients — creates the most commercially dynamic market segment, with the Sandhoff...
0 Commentarii 0 Distribuiri 22 Views 0 previzualizare